Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421991 · ClinicalTrials.gov registry record · NA
Telephone-Delivered Interventions for Smoking Cessation
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 1,275
- Enrollment target
NCT02421991: Completed NA study, sponsored by Fred Hutchinson Cancer Center.
NCT02421991 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 1,275 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02421991, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,275 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that Acceptance and Commitment Therapy's (ACT) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).
Primary Outcome
No smoking in the past 30 days, as reported at 12 month post treatment
Interventions
- BEHAVIORAL Telephone Delivered Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,275 participants |
| Start Date | 2015-11-02 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT02421991 record still lists
NCT02421991 is an interventional study that assigns participants to a tested intervention. Its 1,275 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Telephone Delivered Intervention is the first listed.
NCT02421991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02421991 about?
NCT02421991 is a clinical study titled "Telephone-Delivered Interventions for Smoking Cessation". The purpose of this study is to demonstrate that Acceptance and Commitment Therapy's (ACT) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).
What is the current status of trial NCT02421991?
This trial is currently completed. It is a NA study. The enrollment target is 1,275 participants. The study started on 2015-11-02. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02421991?
The interventions under investigation include: Telephone Delivered Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02421991?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02421991's enrollment target sits among peer trials
1,275 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
- NCT03678025 · 1,273 participants · Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI